The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     
 


Published online October 28, 2009
The Journal of Immunology, 2009, doi:10.4049/jimmunol.0902145
Copyright © 2009 by The American Association of Immunologists, Inc.

This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
jimmunol.0902145v1
183/10/6151    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Google Scholar
Right arrow Articles by Fahey, L. M.
Right arrow Articles by Kast, W. M.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fahey, L. M.
Right arrow Articles by Kast, W. M.

A Major Role for the Minor Capsid Protein of Human Papillomavirus Type 16 in Immune Escape1

Laura M. Fahey,2* Adam B. Raff,2{dagger} Diane M. Da Silva,{ddagger}§ and W. Martin Kast3*{ddagger}§

*Department of Molecular Microbiology and Immunology, {dagger}Systems Biology and Disease Program, {ddagger}Department of Obstetrics and Gynecology and §Norris Comprehensive Cancer Center, University of Southern California, Los Angeles, CA 90033; and Cancer Research Center, University of Hawaii, Honolulu, HI 96822

High-risk human papillomavirus (HPV) infection of the cervical epithelium is causally linked with the generation of cervical cancer. HPV does not activate Langerhans cells (LC), the APC at the site of infection, leading to immune evasion. The HPV protein responsible for inducing this immune escape has not been determined. We demonstrate that LC exposed to the minor capsid protein L2 in HPV16L1L2 virus-like particles do not phenotypically or functionally mature. However, HPV16L1 virus-like particles significantly induce activation of LC. Our data suggest that the L2 protein plays a specific role in the induction of this immune escape of HPV16 through the manipulation of LC. This novel function is the first immune modulating action attributed to the L2 protein and adds significantly to our understanding of the mechanism of HPV immune escape.

3 Address correspondence and reprint requests to Dr. W. Martin Kast, Norris Comprehensive Cancer Center, University of Southern California, 1450 Biggy Street, NRT 7507, Los Angeles, CA 90033. E-mail address: mkast{at}usc.edu

1 This study was supported by National Institutes of Health Grant R01 CA 74397 and 1RC2 CA 148298 (to W.M.K.), National Institutes of Health Training Grant T32 AI07078 (to L.M.F.), and National Institutes of Health Training Grant T32 GM0607587 (to A.B.R.).

2 L.M.F. and A.B.R. contributed equally to this study.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
This Website Copyright © 2009 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2009 by The American Association of Immunologists, Inc. All rights reserved.